CJ
TNXP icon

Caitlin John’s Tonix Pharmaceuticals TNXP Stock Holding History

Caitlin John’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$983 Hold
77
– – ﹤0.01% 873
2026
Q1 		$1.06K Hold
77
– – ﹤0.01% 792
2025
Q4 		$1.2K Buy
+77
New +$1.42K ﹤0.01% 773

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Caitlin John's TNXP Position: Q2 2026 in Review

Caitlin John held its Tonix Pharmaceuticals (TNXP) position steady in Q2 2026 at 77 shares worth $983. The position accounts for ﹤0.01% of the portfolio, ranked #873.

Caitlin John first reported a position in TNXP in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.2K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Caitlin John held 77 shares of Tonix Pharmaceuticals worth $983 as of Q2 2026.
  • Caitlin John left its Tonix Pharmaceuticals share count unchanged in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #873 holding.
  • Caitlin John first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Caitlin John's Tonix Pharmaceuticals position peaked at $1.2K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.